Abstract:Triptolide is the major active component of Tripterygium wilfordii Hook. f., which has been used as an anti-inflammatory agent in traditional Chinese medicine for centuries. The mechanisms of the anti-inflammatory effects of triptolide in renal diseases are not well understood. Recent studies have shown that overexpression of monocyte chemoattractant protein-1 in renal tubular epithelial cells is associated with the inflammatory injuries of renal tubulointerstitium. In this study, we investigated the effect of triptolide on the overexpression of monocyte chemoattractant protein-1 in renal tubular epithelial cells in vitro. Human proximal tubular epithelial cells were treated with gamma interferon (200 μg/L) and tumor necrosis factor-alpha (20 μg/L) or combined with different concentrates of triptolide (0.4, 2, 10 μg/L) for 12 hours (for monocyte chemoattractant protein-1 mRNA measuring) or 24 hours (for monocyte chemoattractant protein-1 protein measuring). The expression of monocyte chemoattractant protein-1 mRNA was detected by using reverse transcriptase-polymerase chain reaction. The expression of monocyte chemoattractant protein-1 protein in the cells was measured by using flow cytometry. Monocyte chemoattractant protein-1 levels in the supernatant were measured by using the enzyme-linked immunosorbent assay method. After treatment with interferon-γ and tumor necrosis factor-α, monocyte chemoattractant protein-1 mRNA and protein levels in human proximal tubular epithelial cells and monocyte chemoattractant protein-1 concentrations in the supernatant were significantly increased. Triptolide (10 μg/L) can significantly inhibit the overexpression of monocyte chemoattractant protein-1 mRNA and protein in human proximal tubular epithelial cells. The increase of monocyte chemoattractant protein-1 protein in the supernatant was also markedly inhibited by triptolide (2, 10 μg/L). The results of this study suggest that the inhibition of monocyte chemoattractant protein-1 overexpression in tubular epithelial cells may contribute to the anti-inflammatory effects of triptolide in renal diseases.

Triptolide Down-Regulates Tumor Necrosis Factor-Α and Interferon-Γ-induced Overexpression of Monocyte Chemoattractant Protein-1 in Human Proximal Tubular Epithelial Cells

Modulatory Effect of Triptolide on Differentiation of Human Th17 Cells

Triptolide Inhibits Proinflammatory Factor-Induced Over-Expression of Class Ii Mhc and B7 Molecules in Renal Tubular Epithelial Cells

TRIPTOLIDE INHIBITS MCP-10VERPRODUCTION IN HUMAN PROXIMAL TUBULAR CELLS INDUCED BYIFNγ AND TNFα COSTIMULATION

Triptolide affects the differentiation, maturation and function of human dendritic cells.

Tripterygium Glycoside Protects Against Puromycin Amino Nucleoside-Induced Podocyte Injury By Upregulating Autophagy

Triptolide protects podocytes via autophagy in immunoglobulin A nephropathy.

Triptolide Inhibits the Proliferation of Cells from Lymphocytic Leukemic Cell Lines in Association with Downregulation of NF-κB Activity and Mir-16-1*.

Triptolide Down-Regulates Indhuced Antigen-Presenting Cell Function of Human Proximal Tubular Epithelial Cells

Triptolide Inhibits Cyclooxygenase-2 and Inducible Nitric Oxide Synthase Expression in Human Colon Cancer and Leukemia Cells

Triptolide reduces proteinuria in experimental membranous nephropathy and protects against C5b-9-induced podocyte injury in vitro.

Triptolide Markedly Attenuates Albuminuria and Podocyte Injury in an Animal Model of Diabetic Nephropathy.

Triptolide protects podocytes from puromycin aminonucleoside induced injury in vivo and in vitro.

Triptolide impairs dendritic cell migration by inhibiting CCR7 and COX-2 expression through PI3-K/Akt and NF-κB pathways

Triptolide Inhibit the Expression of Cyclooxygenase-2(COX-2)and Inducible Nitric Oxide Synthase(iNOS)on Human Colon Cancer Cells

Triptolide Attenuates Oxidative Stress, Nf-Kappa B Activation and Multiple Cytokine Gene Expression in Murine Peritoneal Macrophage

[Effect of Triptolide on TNFalpha-induced Activation of NF-kappaB and Expression of COX-2 and Inos in Human Rheumatoid Arthritis Synovial Fibroblasts].

Triptolide’s anti-inflammatory effects on ARDS by down-regulating miR-9-5p and up-regulating LRG1 and CLDN5

Triptolide Protects Podocytes from TGF-β-induced Injury by Preventing Mir-30 Downregulation.

Triptolide downregulates Rac1 and the JAK/STAT3 pathway and inhibits colitis-related colon cancer progression

Triptolide suppresses IL-1beta-induced chemokine and stromelysin-1 gene expression in human colonic subepithelial myofibroblasts